Merck (MRK) Cash from Investing Activities (2009 - 2026)
Merck (MRK) reported Cash from Investing Activities of -$10.2 billion for Q1 2026, down 586.62% year-over-year from $2.1 billion in Q1 2025, and up 8.85% on a QoQ basis from -$11.2 billion in Q4 2025.
Merck (MRK) has 18 years of Cash from Investing Activities data on file, last reported at -$10.2 billion in Q1 2026.
- Quarterly Cash from Investing Activities fell 586.62% year-over-year to -$10.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.5 billion (down 186.35% YoY) and the FY2025 annual result came in at -$13.7 billion, down 77.67% from the prior year.
- Cash from Investing Activities advanced to -$10.2 billion in Q1 2026 per MRK's latest filing, from -$11.2 billion in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $53.0 million in Q4 2023 and bottomed at -$11.4 billion in Q2 2023.
- The 5-year median for Cash from Investing Activities is -$1.4 billion (2024), against an average of -$3.0 billion.
- The widest annual swing landed in 2023, when Cash from Investing Activities jumped 103.03%; it then tumbled 2824.53% in 2024.
- Tracing MRK's Cash from Investing Activities over 5 years: stood at -$1.7 billion in 2022, then soared by 103.03% to $53.0 million in 2023, then plunged by 2824.53% to -$1.4 billion in 2024, then tumbled by 675.69% to -$11.2 billion in 2025, then advanced by 8.85% to -$10.2 billion in 2026.
- Per Business Quant, the three latest MRK Cash from Investing Activities figures stand at -$10.2 billion (Q1 2026), -$11.2 billion (Q4 2025), and -$283.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -3.92 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -1.04 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -574.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -10.21 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -716.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.77 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 785.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -131.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.21 Bn |
| Mar 31, 2026 | -10.21 Bn |
| Dec 31, 2025 | -11.20 Bn |
| Dec 31, 2025 | -11.20 Bn |
| Sep 30, 2025 | -283.00 Mn |
| Sep 30, 2025 | -283.00 Mn |
| Jun 30, 2025 | -770.00 Mn |
| Jun 30, 2025 | -770.00 Mn |
| Mar 31, 2025 | -1.49 Bn |
| Mar 31, 2025 | -1.49 Bn |
| Dec 31, 2024 | -1.44 Bn |
| Dec 31, 2024 | -1.44 Bn |
| Sep 30, 2024 | -3.85 Bn |
| Sep 30, 2024 | -3.85 Bn |
| Jun 30, 2024 | -1.07 Bn |
| Jun 30, 2024 | -1.07 Bn |
| Mar 31, 2024 | -1.38 Bn |
| Mar 31, 2024 | -1.38 Bn |
| Dec 31, 2023 | 53.00 Mn |
| Dec 31, 2023 | 53.00 Mn |
| Sep 30, 2023 | -334.00 Mn |
| Sep 30, 2023 | -334.00 Mn |
| Jun 30, 2023 | -11.44 Bn |
| Jun 30, 2023 | -11.44 Bn |
| Mar 31, 2023 | -2.36 Bn |
| Mar 31, 2023 | -2.36 Bn |
| Dec 31, 2022 | -1.75 Bn |
| Dec 31, 2022 | -1.75 Bn |
| Sep 30, 2022 | -962.00 Mn |
| Sep 30, 2022 | -962.00 Mn |
| Jun 30, 2022 | -1.08 Bn |
| Jun 30, 2022 | -1.08 Bn |
| Mar 31, 2022 | -1.17 Bn |
| Mar 31, 2022 | -1.17 Bn |
| Dec 31, 2021 | -12.05 Bn |
| Dec 31, 2021 | -12.05 Bn |
| Sep 30, 2021 | -1.06 Bn |
| Sep 30, 2021 | -1.06 Bn |
| Jun 30, 2021 | -2.63 Bn |
| Jun 30, 2021 | -2.63 Bn |
| Mar 31, 2021 | -686.00 Mn |
| Mar 31, 2021 | -686.00 Mn |
| Dec 31, 2020 | -4.70 Bn |
| Dec 31, 2020 | -4.70 Bn |
| Sep 30, 2020 | -2.09 Bn |
| Sep 30, 2020 | -2.09 Bn |
| Jun 30, 2020 | -782.00 Mn |
| Jun 30, 2020 | -782.00 Mn |
| Mar 31, 2020 | -1.63 Bn |
| Mar 31, 2020 | -1.63 Bn |
| Dec 31, 2019 | -663.00 Mn |
| Dec 31, 2019 | -663.00 Mn |
| Sep 30, 2019 | 191.00 Mn |
| Sep 30, 2019 | 191.00 Mn |
| Jun 30, 2019 | -2.43 Bn |
| Jun 30, 2019 | -2.43 Bn |
| Mar 31, 2019 | 368.00 Mn |
| Mar 31, 2019 | 368.00 Mn |
| Dec 31, 2018 | 2.18 Bn |
| Dec 31, 2018 | 2.18 Bn |
| Sep 30, 2018 | 1.66 Bn |
| Sep 30, 2018 | 1.66 Bn |
| Jun 30, 2018 | 673.00 Mn |
| Jun 30, 2018 | 673.00 Mn |
| Mar 31, 2018 | -197.00 Mn |
| Mar 31, 2018 | -197.00 Mn |
| Dec 31, 2017 | -58.00 Mn |
| Dec 31, 2017 | -58.00 Mn |
| Sep 30, 2017 | 671.00 Mn |
| Sep 30, 2017 | 671.00 Mn |
| Jun 30, 2017 | -1.13 Bn |
| Jun 30, 2017 | -1.13 Bn |
| Mar 31, 2017 | 3.19 Bn |
| Mar 31, 2017 | 3.19 Bn |
| Dec 31, 2016 | -2.56 Bn |
| Dec 31, 2016 | -2.56 Bn |
| Sep 30, 2016 | -890.00 Mn |
| Sep 30, 2016 | -890.00 Mn |
| Jun 30, 2016 | -1.50 Bn |
| Jun 30, 2016 | -1.50 Bn |
| Mar 31, 2016 | 1.74 Bn |
| Mar 31, 2016 | 1.74 Bn |
| Dec 31, 2015 | -617.00 Mn |
| Dec 31, 2015 | -617.00 Mn |
| Sep 30, 2015 | -61.00 Mn |
| Sep 30, 2015 | -61.00 Mn |
| Jun 30, 2015 | 2.53 Bn |
| Jun 30, 2015 | 2.53 Bn |
| Mar 31, 2015 | -6.61 Bn |
| Mar 31, 2015 | -6.61 Bn |
| Dec 31, 2014 | 7.20 Bn |
| Dec 31, 2014 | 7.20 Bn |
| Sep 30, 2014 | -3.72 Bn |
| Sep 30, 2014 | -3.72 Bn |
| Jun 30, 2014 | -49.00 Mn |
| Jun 30, 2014 | -49.00 Mn |
| Mar 31, 2014 | -3.81 Bn |
| Mar 31, 2014 | -3.81 Bn |
| Dec 31, 2013 | 1.18 Bn |
| Dec 31, 2013 | 1.18 Bn |
| Sep 30, 2013 | -2.04 Bn |
| Sep 30, 2013 | -2.04 Bn |
| Jun 30, 2013 | -1.14 Bn |
| Jun 30, 2013 | -1.14 Bn |
| Mar 31, 2013 | -1.15 Bn |
| Mar 31, 2013 | -1.15 Bn |
| Dec 31, 2012 | -4.40 Bn |
| Dec 31, 2012 | -4.40 Bn |
| Sep 30, 2012 | -1.84 Bn |
| Sep 30, 2012 | -1.84 Bn |
| Jun 30, 2012 | -298.00 Mn |
| Jun 30, 2012 | -298.00 Mn |
| Mar 31, 2012 | -270.00 Mn |
| Mar 31, 2012 | -270.00 Mn |
| Dec 31, 2011 | -1.68 Bn |
| Dec 31, 2011 | -1.68 Bn |
| Sep 30, 2011 | -263.00 Mn |
| Sep 30, 2011 | -263.00 Mn |
| Jun 30, 2011 | -1.05 Bn |
| Jun 30, 2011 | -1.05 Bn |
| Mar 31, 2011 | 105.00 Mn |
| Mar 31, 2011 | 105.00 Mn |
| Dec 31, 2010 | -1.01 Bn |
| Dec 31, 2010 | -1.01 Bn |
| Sep 30, 2010 | 194.00 Mn |
| Sep 30, 2010 | 194.00 Mn |
| Jun 30, 2010 | 464.00 Mn |
| Jun 30, 2010 | 464.00 Mn |
| Mar 31, 2010 | -3.15 Bn |
| Mar 31, 2010 | -3.15 Bn |
| Dec 31, 2009 | -12.86 Bn |
| Dec 31, 2009 | -12.86 Bn |
| Sep 30, 2009 | 12.01 Bn |
| Sep 30, 2009 | 12.01 Bn |
| Jun 30, 2009 | 2.62 Bn |
| Jun 30, 2009 | 2.62 Bn |
| Mar 31, 2009 | 1.39 Bn |
| Mar 31, 2009 | 1.39 Bn |